BiotechTube

OAC alone

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Atrial Fibrillation

Conditions

Atrial Fibrillation, Coronary Artery Disease

Trial Timeline

Nov 5, 2013 → May 18, 2018

NCT ID
NCT01962545

About OAC alone

OAC alone is a approved stage product being developed by Daiichi Sankyo for Atrial Fibrillation. The current trial status is completed. This product is registered under clinical trial identifier NCT01962545. Target conditions include Atrial Fibrillation, Coronary Artery Disease.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01962545ApprovedCompleted

Competing Products

20 competing products in Atrial Fibrillation

See all competitors
ProductCompanyStageHype Score
EdoxabanDaiichi SankyoPre-clinical
23
Edoxaban + Clopidogrel + Prasugrel + Ticagrelor + Vitamin K antagonistDaiichi SankyoPhase 3
77
Edoxaban + ASADaiichi SankyoPhase 3
77
DU-176b tablets + DU-176b tablets + Warfarin tabletsDaiichi SankyoPhase 2
52
Edoxaban + Apixaban + RivaroxabanDaiichi SankyoPre-clinical
23
Edoxaban + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen + VKA-Based RegimenDaiichi SankyoPhase 3
77
Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarinDaiichi SankyoPhase 2
52
EdoxabanDaiichi SankyoPre-clinical
23
EdoxabanDaiichi SankyoApproved
85
Edoxaban + Warfarin + EnoxaparinDaiichi SankyoPhase 3
77
EdoxabanDaiichi SankyoPre-clinical
23
EdoxabanDaiichi SankyoPre-clinical
23
DU-176b 15mg + DU-176b 30mg + DU-176b 60mgDaiichi SankyoPhase 3
77
dabigatran, rivaroxaban, apixaban or edoxabanDaiichi SankyoPre-clinical
23
EdoxabanDaiichi SankyoPre-clinical
23
DU-176b tablets + Warfarin potassium tabletsDaiichi SankyoPhase 2
52
Edoxaban-based Regimen + VKA-based RegimenDaiichi SankyoPhase 3
77
EdoxabanDaiichi SankyoPre-clinical
23
Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
85
EdoxabanDaiichi SankyoPre-clinical
23

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85
colesevelam HCl + placeboApproved
85